| Pamela Brown, MD | |
|
6487 Nc Highway 11 N, Bethel, NC 27812-9797 | |
| (919) 802-4589 | |
| Not Available |
| Full Name | Pamela Brown |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 6487 Nc Highway 11 N, Bethel, North Carolina |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811910516 | NPI | - | NPPES |
| 3000161 | Other | WV | BWC |
| 64056096 | Medicaid | KY | |
| 5908320 | Medicaid | NC | |
| 3810004962 | Medicaid | WV | |
| 000000233250 | Other | KY | ANTHEM |
| 50005447 | Other | KY | PASSPORT |
| 930124031 | Other | KY | RR-MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Home Care & Hospice | Wilson, NC | Hospice |
| Community Hospice Llc | New bern, NC | Hospice |
| Universal Health Care / Greenville | Greenville, NC | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eventus Wholehealth Pllc | 6002169539 | 242 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | North Carolina Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003861386 PECOS PAC ID: 1355254947 Enrollment ID: O20031110000563 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Halifax Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992846570 PECOS PAC ID: 5496664062 Enrollment ID: O20031125000253 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | The Carolinas Emergency Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477508836 PECOS PAC ID: 2567486814 Enrollment ID: O20060125000577 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Vidant Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477648731 PECOS PAC ID: 0345343893 Enrollment ID: O20070321000445 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Doctors Making Housecalls Family Medicine,pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275773087 PECOS PAC ID: 1153473723 Enrollment ID: O20090806000567 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20100202000365 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Kinston Physicians Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689923757 PECOS PAC ID: 6204087919 Enrollment ID: O20121106000298 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Bull City Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770004285 PECOS PAC ID: 6901164938 Enrollment ID: O20171221001735 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Eventus Wholehealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548759392 PECOS PAC ID: 6002169539 Enrollment ID: O20181030001281 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Entity Name | Dr. Duck Family Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588344238 PECOS PAC ID: 9335500636 Enrollment ID: O20230803000220 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pamela Brown, MD 101 Cabarrus Ave E, Concord, NC 28025-3699 Ph: (855) 743-2247 | Pamela Brown, MD 6487 Nc Highway 11 N, Bethel, NC 27812-9797 Ph: (919) 802-4589 |
News Archive
Researchers at Oregon State University have discovered that some compounds called polyoxoniobates can degrade and decontaminate nerve agents such as the deadly sarin gas, and have other characteristics that may make them ideal for protective suits, masks or other clothing.
McGill University Health Centre (MUHC) scientists have discovered that our body's own defense mechanism causes some of the most serious asthma symptoms.
A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
› Verified 1 days ago
Dr. Richard P Rawl, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 Railroad St W, Ecu Physicians Family Medicine, Bethel, NC 27812 Phone: 252-744-0355 Fax: 252-744-0350 |